Epidemiological trends and treatment abandonment of paediatric solid tumours in a nigerian tertiary hospital: a seven-year review (2016-2022).

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE
    • Publication Information:
      Original Publication: London : BioMed Central, [2001-
    • Subject Terms:
      Tertiary Care Centers*/statistics & numerical data ; Neoplasms*/epidemiology ; Neoplasms*/therapy; Humans ; Nigeria/epidemiology ; Male ; Female ; Child ; Retrospective Studies ; Child, Preschool ; Adolescent ; Infant ; Prevalence ; Treatment Outcome
    • Abstract:
      Background: Paediatric solid tumours, both benign and malignant, present significant health challenges, particularly in Sub-Saharan Africa where comprehensive data is limited. This study aims to elucidate the prevalence, distribution, and treatment outcomes of paediatric solid neoplasms in a tertiary hospital in South-East Nigeria over a seven-year period.
      Methods: A retrospective cohort study was conducted at Nnamdi Azikiwe University Teaching Hospital (NAUTH), Nnewi, Nigeria. Clinical details and histological slides of confirmed cases from January 2016 to December 2022 were reviewed. Data extraction focused on socio-demographic variables and treatment outcomes, analysed using statistical methods.
      Results: The study included 293 children diagnosed with solid tumours (58.1% malignant, 41.9% benign), with a female predominance (61.8%). The median age at diagnosis was 12 years. Fibroadenoma was the most common benign tumour (61.8% of benign cases), while non-Hodgkin lymphoma was the predominant malignant tumour (18.2% of malignant cases). Treatment abandonment rates differed significantly between benign (13.8%) and malignant (51.2%) tumours. Significant associations were found between treatment outcomes and factors such as gender (p = 0.0001 for benign tumours), age category (p = 0.0001 for benign tumours), and specific diagnoses (p = 0.0001 for both benign and malignant tumours).
      Conclusion: This study underscores the substantial burden of paediatric solid tumours in South-East Nigeria and highlights the critical need for improved treatment adherence strategies, particularly for malignant cases. The findings emphasize the importance of tailored interventions based on tumour type, age, and gender. These insights can inform future research, policy formulation, and healthcare strategies aimed at enhancing the management and outcomes of paediatric solid neoplasms in resource-limited settings.
      (© 2024. The Author(s).)
    • References:
      Br J Cancer. 2010 Nov 23;103(11):1663-70. (PMID: 21063404)
      Cancer Epidemiol. 2021 Apr;71(Pt B):101662. (PMID: 31924557)
      Children (Basel). 2018 Oct 23;5(11):. (PMID: 30360527)
      Support Care Cancer. 2018 Mar;26(3):967-973. (PMID: 28986643)
      Asian Pac J Cancer Prev. 2019 Apr 29;20(4):1133-1137. (PMID: 31030486)
      Pediatr Blood Cancer. 2013 Jun;60(6):1001-8. (PMID: 23255356)
      Nat Rev Dis Primers. 2016 Nov 10;2:16078. (PMID: 27830764)
      Lancet Oncol. 2011 Aug;12(8):719-20. (PMID: 21719348)
      J Trop Pediatr. 2015 Jun;61(3):165-73. (PMID: 25724211)
      CA Cancer J Clin. 2018 Nov;68(6):394-424. (PMID: 30207593)
      Lancet Oncol. 2022 Jun;23(6):719-728. (PMID: 35550275)
      J Adv Nurs. 2018 Apr;74(4):800-808. (PMID: 29023923)
      Ghana Med J. 2007 Jun;41(2):78-81. (PMID: 17925847)
      PLoS One. 2016 Oct 13;11(10):e0163090. (PMID: 27736871)
      Int J Womens Health. 2023 May 18;15:765-778. (PMID: 37223067)
      J Pediatr Nurs. 2003 Apr;18(2):96-102. (PMID: 12720206)
      Blood. 2011 Jun 2;117(22):5803-15. (PMID: 21398581)
      Lancet Oncol. 2023 Jan;24(1):3-4. (PMID: 36603920)
      West Afr J Med. 2008 Jan;27(1):3-6. (PMID: 18689295)
      BMJ Open. 2022 Apr 11;12(4):e054690. (PMID: 35410925)
      Lancet. 2017 Jul 1;390(10089):85-94. (PMID: 28089471)
      Cancer Sci. 2010 Mar;101(3):787-92. (PMID: 20132215)
      Pediatr Blood Cancer. 2007 Dec;49(7):941-6. (PMID: 17252565)
      Handb Clin Neurol. 2013;111:333-40. (PMID: 23622184)
      Pediatr Blood Cancer. 2018 Aug;65(8):e27073. (PMID: 29741220)
      Afr J Paediatr Surg. 2009 Jan-Jun;6(1):7-10. (PMID: 19661657)
      Int J Cancer. 2021 Feb 15;148(4):895-904. (PMID: 32875569)
      Curr Opin Pediatr. 2009 Jun;21(3):357-64. (PMID: 19417665)
    • Contributed Indexing:
      Keywords: Epidemiology; Neoplasm prevalence; Nigeria; Paediatric solid tumours; Retrospective study; Treatment adherence
    • Publication Date:
      Date Created: 20240802 Date Completed: 20240803 Latest Revision: 20240805
    • Publication Date:
      20240805
    • Accession Number:
      PMC11295635
    • Accession Number:
      10.1186/s12885-024-12723-7
    • Accession Number:
      39095784